Filing Details
- Accession Number:
- 0001104659-12-079265
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2012-11-20 16:12:07
- Reporting Period:
- 2012-11-12
- Filing Date:
- 2012-11-20
- Accepted Time:
- 2012-11-20 16:12:07
- Original Submission Date:
- 2012-11-13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113784 | Cardionet Inc. | BEAT | Surgical & Medical Instruments & Apparatus (3841) | 330604557 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1201075 | A Ronald Ahrens | 227 Washington Street, #300 Conshohocken PA 19428 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-11-12 | 15,000 | $2.22 | 129,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents 109,550 shares of the Issuer's common stock underlying restricted stock units (RSUs) awarded to the Reporting Person. The RSUs will vest proportionally over the four (4) successive quarters following the award date. In the event of the occurrence of the Reporting Person's death, Disability (within the meaning of such term under section 409A(a)(2)(C) of the Internal Revenue Code of 1986, as amended (the "Code")), "separation from service" (within the meaning of such term under Code section 409A(a)(2)(A)(i)) or a 409A Change in Control Event (as defined in the award agreement) prior to the full vesting date, all outstanding RSUs shall be fully vested. The shares of common stock underlying the RSUs will be issued when the RSUs vest.
- The price reported in column 4 is a weighted price. These shares were purchased in multiple transactions at prices and ranges from $2.12-$2.25, inclusive. The reporting person undertakes to provide to CardioNet, Inc., any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.